Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 9 (2009), Pages 967-969
http://dx.doi.org/10.1100/tsw.2009.104
Editorial

Enhancing the Delivery of Erythropoietin and Its Variants into the Ischemic Brain

Department of Neurology, University Hospital Essen, Germany

Received 26 August 2009; Accepted 26 August 2009

Copyright © 2009 Dirk Hermann.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Julio Cesar Garcia Rodriguez, and Iliana Sosa Teste, “The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans,” Thescientificworldjournal, vol. 9, pp. 970–981, 2009. View at Publisher · View at Google Scholar
  • Yamila Rodriguez Cruz, Yuneidys Mengana Tamos, Adriana Munoz Cernuda, Nelvis Subiros Martines, Alina Gonzalez-Quevedo, Iliana Sosa Teste, and Julio Cesar Garcia Rodriguez, “Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia,” Thescientificworldjournal, vol. 10, pp. 2288–2300, 2010. View at Publisher · View at Google Scholar
  • Dirk M. Hermann, “Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies,” Thescientificworldjournal, vol. 10, pp. 2285–2287, 2010. View at Publisher · View at Google Scholar
  • Dong-Hyuk Park, David J. Eve, Yong-Gu Chung, and Paul R. Sanberg, “Regenerative Medicine for Neurological Disorders,” Thescientificworldjournal, vol. 10, pp. 470–489, 2010. View at Publisher · View at Google Scholar
  • Amalia Merelli, Laura Caltana, Alberto Lazarowski, and Alicia Brusco, “Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia,” Drug Metabolism and Drug Interactions, vol. 26, no. 2, pp. 65–69, 2011. View at Publisher · View at Google Scholar
  • Theodoros Xanthos, Panagiotis V.S. Vasileiou, Sotirios Kakavas, Aggeliki Syggelou, and Nicoletta Iacovidou, “The potential role of erythropoietin as a pleiotropic agent in post-cardiac arrest syndrome,” Current Pharmaceutical Design, vol. 17, no. 15, pp. 1517–1529, 2011. View at Publisher · View at Google Scholar
  • Sermin Genc, Zeynep Zadeoglulari, Meryem Gulfem Oner, Kursad Genc, and Murat Digicaylioglu, “Intranasal erythropoietin therapy in nervous system disorders,” Expert Opinion on Drug Delivery, vol. 8, no. 1, pp. 19–32, 2011. View at Publisher · View at Google Scholar
  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Saravanan S Karuppagounder, and Rajiv R Ratan, “Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?,” Journal of Cerebral Blood Flow & Metabolism, vol. 32, no. 7, pp. 1347–1361, 2012. View at Publisher · View at Google Scholar
  • Iliana Sosa Teste, Yuneidys Mengana Tamos, Yamila Rodríguez Cruz, Adriana Muñoz Cernada, Janette Cruz Rodríguez, Nelvis Subirós Martínez, Rosa Maria Coro Antich, Alina González-Quevedo, and Julio Cesar García Rodríguez, “Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil,” The Scientific World Journal, vol. 2012, pp. 1–12, 2012. View at Publisher · View at Google Scholar
  • Selvan, Nath, Zhou, Rosenbaum, and Barone, “Inhibiting prolyl hydroxylase induces ischemic preconditioning pathways and reduces stroke brain injury,” Drugs of the Future, vol. 42, no. 4, pp. 215–224, 2017. View at Publisher · View at Google Scholar
  • Steven C. Cramer, “Treatments to Promote Neural Repair after Stroke,” Journal of Stroke, vol. 20, no. 1, pp. 57–70, 2018. View at Publisher · View at Google Scholar